Abstracts tagged "Marketing"

Abstract Number: 1857 • 2017 ACR/ARHP Annual Meeting
If Mobile Advertising Is the Future, the Future Is Now: Productivity of Digital Ads By Terminology and Delivery Device.
Teresa J. Brady¹ and Kamil E. Barbour², ¹Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ²Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: CDC is pilot-testing a multi-modal marketing campaign to promote self-management education (SME) as a chronic disease management strategy. The campaign targets adults ages 45-75…
Abstract Number: 2020 • 2016 ACR/ARHP Annual Meeting
Making the Case for Self-Management Education: Marketing Lessons Learned from Qualitative Research
Teresa J. Brady¹, Bithiah Lafontant², Tai Baker³ and Rebecca Ledsky⁴, ¹Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ²FHI 360, Washington, DC, ³Centers for Disease Control and Prevention, Atlanta, GA, ⁴Social Marketing and Communication, FHI 360, Washington, DC
Background/Purpose: Self-management education (SME) uses educational and behavioral strategies to help people with arthritis (PWA) and other chronic conditions (CC) develop healthy behaviors and gain…
Abstract Number: 127 • 2015 ACR/ARHP Annual Meeting
Potential Use of Healthcare Databases for Post-Marketing Surveillance Registry: an Example Using Ustekinumab
Huifeng Yun¹, Shuo Yang², Fenglong Xie³, Lang Chen⁴, Kevin L. Winthrop⁵ and Jeffrey R. Curtis⁴, ¹Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ²Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ⁴University of Alabama at Birmingham, Birmingham, AL, ⁵Oregon Health and Science University, Portland, OR
Background/Purpose: Underreporting and inherent deficiencies are common using spontaneous reports for post-marketing surveillance. The U.S. Food and Drug Administration (FDA) has recommended sponsors to collect…

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.